Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Year: 2013
Type: article
Source: Schizophrenia Research
Authors: Stephen R. Marder, Larry Alphs, Ion-George Anghelescu, Celso Arango, Thomas R.E. Barnes, Ivo Caers, David G. Daniel, Eduardo Dunayevich, W. Wolfgang Fleischhacker, George Garibaldi, Michael F. Green, Philip D. Harvey, René S. Kahn, John M. Kane, Richard S.E. Keefe, Bruce Kinon, Stefan Leucht, Jean-Pierre Lindenmayer, Anil K. Malhotra, Virginia Stauffer, Daniel Umbricht, Keith Wesnes, Shitij Kapur, Jonathan Rabinowitz
Institutions: University of California, Los Angeles, Janssen Scientific Affairs (United States), Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Investigación Sanitaria Gregorio Marañón, Imperial College London, Janssen (Belgium), Amgen (United States), Innsbruck Medical University, F. Hoffmann-La Roche AG, University of Miami, University Medical Center Utrecht, Zucker Hillside Hospital, Duke University, Duke Medical Center, Eli Lilly (United States), Technical University of Munich, New York University, King's College London, Bar-Ilan University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2032604382